Rising levels of obesity are set to cost the world economy 3.3 percent of GDP by 2060, slowing development in lower-income countries, according to a study published in BMJ Global Health.
The conditions currently cost 2.2 percent of global GDP, and the biggest increases are expected in lower-resourced countries.
In terms of absolute costs, China, the US, and India are expected to bear the brunt of the damage, with costs of $10 trillion, $2.5 trillion, and $850 billion, respectively.
The worst affected nations are anticipated to be Trinidad and Tobago with 10.2 percent of GDP and the United Arab Emirates with 11.0% of GDP being accounted for by obesity.
Both direct costs, namely medical expenses, and indirect costs from early mortality and lost output were examined in the report.
The study offers the first estimate of the economic effects of obesity, a major contributor to other non-communicable diseases like cancer, diabetes, and heart disorders, on a country-by-country basis.
According to lead author Rachel Nugent at a briefing on the margins of the UN General Assembly, nearly two in three adults globally are now living with obesity and project there would be three in four adults by 2060.


Asian Markets Rally as Oil Prices Tumble and Middle East Peace Hopes Emerge
Rio Tinto's Resolution Copper Mine: U.S. Smelting Challenges and Global Operations Update
Reflection AI Eyes $25 Billion Valuation in Massive $2.5 Billion Funding Round
France's 2025 Budget Deficit Shrinks More Than Expected, Easing Fiscal Pressure
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
Merck's $6 Billion Bid for Terns Pharma Signals Bold Oncology Push
Meta Ties Executive Pay to Aggressive Stock Price Targets in Major Retention Push
Federal Reserve Balance Sheet Reduction: Brookings Research Outlines Possible Path Forward
FDA Fast-Track Drug Reviews Delayed Over Safety and Efficacy Concerns
Bank of Japan Unveils New Inflation Gauge to Support Case for Future Rate Hikes
Asian Currencies Stay Muted as Dollar Holds Firm Amid Iran Uncertainty
SK Hynix Eyes Up to $14 Billion U.S. IPO to Fund AI Chip Expansion
Gold Prices Climb as Middle East Ceasefire Talks Stir Market Optimism
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans 



